Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Driehaus Capital Management LLC | SONX Sonendo, Inc. | 13G/A | 4.85% | Jan 31, 2024 | 2y |
| WOLVERINE ASSET MANAGEMENT LLC | CSTAF Constellation Acquisition Corp I | 13G/A | 1.97% | Jan 29, 2024 | 2y |
| Paradigm Biocapital Advisors LP | CRBP Corbus Pharmaceuticals Holdings, Inc. | 13G | 0% | Jan 26, 2024 | 2y |
| Zambon SpA (“ZSPA”) | SVRA Savara Inc | 13G/A | 3.46% | Jan 24, 2024 | 2y |
| WOLVERINE ASSET MANAGEMENT LLC | BRAC Broad Capital Acquisition Corp Common Stock | 13G/A | 0.74% | Jan 22, 2024 | 2y |
| Garo H. Armen | INKT MiNK Therapeutics, Inc. | 13D | 9.68% | Jan 16, 2024 | 2y |
| WOLVERINE ASSET MANAGEMENT LLC | ESYN EnerSyn Global Inc. | 13G/A | 0% | Jan 12, 2024 | 2y |
| Greater Miami Jewish Federation, Inc. | RDVT Red Violet, Inc. | 13G/A | 8.2% | Jan 1, 2024 | 2y |
| WINDACRE PARTNERSHIP LLC | HLF Herbalife Ltd. | 13G/A | 8.98% | Dec 31, 2023 | 2y |
| Magnetar Financial LLC | WHLR Wheeler Real Estate Investment Trust, Inc. | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| LONE PINE CAPITAL LLC | DKS Dick's Sporting Goods, Inc. | 13G/A | 5% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | CCC CCC Intelligent Solutions Holdings Inc. | 13G | 5.6% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | SYRE Spyre Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Blue Owl Capital Holdings LP | TRML Tourmaline Bio, Inc. Common Stock | 13G | 6.55% | Dec 31, 2023 | 2y |
| BHP Group Limited | IE Ivanhoe Electric Inc. | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| Gates Capital Management, Inc. | MBC MasterBrand, Inc. | 13G/A | 7.2% | Dec 31, 2023 | 2y |
| Ionic Ventures, LLC | BDRX Biodexa Pharmaceuticals Plc | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| Cormorant Asset Management, LP | LBPH Longboard Pharmaceuticals, Inc. Common Stock | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | SCI Service Corp International | 13G/A | 3.3% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | RDNW RideNow Group, Inc. | 13G/A | 12.6% | Dec 31, 2023 | 2y |
| Jixun Foo | HERE Here Group Ltd | 13G | 6.5% | Dec 31, 2023 | 2y |
| Opaleye Management Inc. | SNWV SANUWAVE Health, Inc. | 13G/A | 9.09% | Dec 31, 2023 | 2y |
| CP BF Lending, LLC | EBET EBET, INC. Common Stock | 13G | 9.99% | Dec 31, 2023 | 2y |
| SPRUCE HOUSE INVESTMENT MANAGEMENT LLC | CVNA Carvana Co. | 13G/A | 8.4% | Dec 31, 2023 | 2y |
| Snyder Capital Management, L.P. | OPLN OPENLANE, Inc. | 13G/A | 3.77% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | PLRX Pliant Therapeutics, Inc. | 13G/A | 4.5% | Dec 31, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | TRVI Trevi Therapeutics, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | JNCE Jounce Therapeutics, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Commodore Capital LP | SLNO Soleno Therapeutics Inc | 13G/A | 2.3% | Dec 31, 2023 | 2y |
| Walleye Capital LLC | VMCAF Valuence Merger Corp. I | 13G | 9.36% | Dec 31, 2023 | 2y |
| Almitas Capital LLC | DTF Dtf Tax-Free Income 2028 Term Fund Inc | 13G | 5% | Dec 31, 2023 | 2y |
| MANGROVE PARTNERS IM, LLC | CNTM ConnectM Technology Solutions, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| MANGROVE PARTNERS IM, LLC | RNAC Cartesian Therapeutics, Inc. | 13G/A | 2.59% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | ELS Equity Lifestyle Properties Inc | 13G | 7.2% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | TCN Tricon Residential Inc. | 13G | 6.8% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | CMI Cummins Inc | 13G | 5.2% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | CHWY Chewy, Inc. | 13G/A | 1.3% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | BROS Dutch Bros Inc. | 13G | 6.6% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | TFX Teleflex Inc | 13G/A | 15% | Dec 31, 2023 | 2y |
| Westchester Capital Management, LLC | ONMD OneMedNet Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| First Light Asset Management, LLC | PLRX Pliant Therapeutics, Inc. | 13G | 6.14% | Dec 31, 2023 | 2y |
| Deer IX & Co. Ltd. | WEAV Weave Communications, Inc. | 13G/A | 10.3% | Dec 31, 2023 | 2y |
| ORBIMED ADVISORS LLC | ELEV Elevation Oncology, Inc. Common stock | 13G | 6.8% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | BCRX Biocryst Pharmaceuticals Inc | 13G/A | 4.98% | Dec 31, 2023 | 2y |
| CANADA PENSION PLAN INVESTMENT BOARD | SRAD Sportradar Group AG | 13G/A | 38.5% | Dec 31, 2023 | 2y |
| Fourthstone LLC | CBAN Colony Bankcorp Inc | 13G/A | 8.22% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | KOPN Kopin Corp | 13G | 9.99% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | PTN Palatin Technologies Inc | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | ABEO Abeona Therapeutics Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | HOLX HOLOGIC INC | 13G | 9.2% | Dec 31, 2023 | 2y |